Delineating the Psychiatric Morbidity Spectrum in Congenital Adrenal Hyperplasia: A Population-based Registry Study
The Journal of Clinical Endocrinology & Metabolism · 15.07.2025 · 110 (8) · 2147-2156
DOI: 10.1210/clinem/dgae780 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 15.11.2024. Verfasst von Marie Lind-Holst und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hans Christian Andersen Children's Hospital, Odense University Hospital, 5000 Odense C, Denmark. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Mental Disorders, Antipsychotic Agents, Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: International Fund of Congenital Adrenal Hyperplasia, Aase and Ejnar Danielsen Fund, Central Denmark Region Health Research Fund.
Abstract (Originalsprache)
Context
Clinical studies of psychiatric morbidity in patients with congenital adrenal hyperplasia (CAH) imply impaired mental health.
Objective
To delineate psychiatric morbidity in a national CAH cohort by using complete data on psychiatric diagnoses from all Danish hospitals between 1977 and 2018 and on all psychiatric medication prescribed between 1995 and 2018.
Design
A registry-based cohort study.
Setting
A uniform public health care system. Patients and controls Four hundred and forty-eight patients (females: n = 215) with CAH, of which 410 had 21-hydroxylase deficiency (21-OHD) (females: n = 255) and 44 527 were age- and sex-matched general population controls. Main outcome measures Diagnoses were analyzed by negative binomial regression yielding incidence rate ratios (IRR). Medication were analyzed by Cox regression yielding hazard ratios (HR).
Results
21-OHD was associated with an increased risk of any psychiatric diagnosis; females: IRR = 2.32 (CI, 1.48-3.64), males: IRR = 2.74 (CI, 1.31-5.71) as well as of medication related to psychiatric disorders; females: HR = 1.74 (CI, 1.42-2.13), males: HR = 1.74 (CI, 1.30-2.33). Both females and males with 21-OHD had a significantly increased risk of alcohol use, stress and adjustment disorders, and of suicidal behavior. For patients with more rare forms of CAH (n = 24), the risk of any psychiatric diagnosis was significantly increased for males, IRR = 12.85 (CI, 1.78-92.87), but not for females, IRR = 0.54 (CI, 0.10-3.00). The risk of being prescribed psychiatric medication was not increased for neither females, HR = 1.05 (CI, 0.39-2.84), nor males, HR = 0.72 (CI, 0.10-5.13), with rare forms of CAH.
Conclusion
21-OHD is associated with a significantly increased psychiatric morbidity. This study underlines a need for awareness of mental health in patients with 21-OHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Hans Christian Andersen Children's Hospital, Odense University Hospital, 5000 Odense C, Denmark.
- Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
- Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen Ø, Denmark.
- Research center EDMaRC, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen Ø, Denmark.
- Department of Endocrinology, Odense University Hospital, 5000 Odense C, Denmark.
- Department of Clinical Genetics, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen Ø, Denmark.
ORCID-Profile: Marie Lind-Holst, Dorte Hansen, Katharina Maria Main, Anders Juul, Marianne Skovsager Andersen, Åse Krogh Rasmussen, Niels Jørgensen, Claus Højbjerg Gravholt, Agnethe Berglund
Förderung
- International Fund of Congenital Adrenal Hyperplasia
- Aase and Ejnar Danielsen Fund
- Central Denmark Region Health Research Fund
- Fonden til Lægevidenskabens Fremme
- Southern Denmark University
- Southern Denmark Region Research Fund
Zitieren
APA
Lind-Holst, M., Hansen, D., Main, K. M., Juul, A., Andersen, M. S., Dunø, M., Rasmussen, Å. K., Jørgensen, N., Gravholt, C. H., & Berglund, A. (2025). Delineating the Psychiatric Morbidity Spectrum in Congenital Adrenal Hyperplasia: A Population-based Registry Study. The Journal of Clinical Endocrinology & Metabolism, 110(8), 2147-2156. https://doi.org/10.1210/clinem/dgae780
Vancouver
Lind-Holst M, Hansen D, Main KM, Juul A, Andersen MS, Dunø M, et al. Delineating the Psychiatric Morbidity Spectrum in Congenital Adrenal Hyperplasia: A Population-based Registry Study. The Journal of Clinical Endocrinology & Metabolism. 2025;110(8):2147-2156. doi:10.1210/clinem/dgae780
BibTeX
@article{LindHolst2025,
author = {Lind-Holst, Marie and Hansen, Dorte and Main, Katharina Maria and Juul, Anders and Andersen, Marianne Skovsager and Dunø, Morten and Rasmussen, Åse Krogh and Jørgensen, Niels and Gravholt, Claus Højbjerg and Berglund, Agnethe},
title = {Delineating the Psychiatric Morbidity Spectrum in Congenital Adrenal Hyperplasia: A Population-based Registry Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {8},
pages = {2147--2156},
doi = {10.1210/clinem/dgae780}
}
EUVIMED